✦ LIBER ✦

P-665 Prognostic assessment of patients with lung adenocarcinoma:Immunohistochemical expression of thyroid transcription factor-1 and matrix metalloproteinase-9

✍ Scribed by Martins, S.; Takagaki, T.; Ho, N.; Capelozzi, V.

Book ID: 123242376
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 147 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(05)81158-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of matrix metalloproteinase 9

Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma

✍ Koh-ichi Sakata; Masaaki Satoh; Masanori Someya; Hiroko Asanuma; Hisayasu Nagaku 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

## Abstract ## BACKGROUND Non‐Hodgkin lymphoma (NHL) represents a heterogeneous group of tumors that vary with regard to their biologic aggressiveness and clinical course. In in vitro studies, matrix metalloproteinase 9 (MMP9) was reportedly expressed by human NHL cells and elevated levels of MMP9

Assessment of VEGF-D expression measured

Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma

✍ Lina Zhang; Kotaro Higashi; Yasuhito Ishigaki; Yoshimichi Ueda; Tsutomu Sakuma; 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 279 KB

Expression levels of vascular endothelia

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

✍ L Manenti; P Paganoni; I Floriani; F Landoni; V Torri; A Buda; G Taraboletti; R 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 259 KB